Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Olga Osokina, M.D.

Concepts (12)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Olga Osokina's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Olga Osokina has written about over time.
Anti-Bacterial Agents, 1 publications between 1996 and 1996, average publication date December 1995. Cefuroxime, 1 publications between 1996 and 1996, average publication date December 1995. Cephalosporins, 1 publications between 1996 and 1996, average publication date December 1995. Gram-Negative Bacteria, 1 publications between 1996 and 1996, average publication date December 1995. Gram-Positive Bacteria, 1 publications between 1996 and 1996, average publication date December 1995. Microbial Sensitivity Tests, 1 publications between 1996 and 1996, average publication date December 1995. Adolescent, 1 publications between 2022 and 2022, average publication date October 2022. Cross-Sectional Studies, 1 publications between 2022 and 2022, average publication date October 2022. Humans, 1 publications between 2022 and 2022, average publication date October 2022. Mental Health, 1 publications between 2022 and 2022, average publication date October 2022. Stress Disorders, Post-Traumatic, 1 publications between 2022 and 2022, average publication date October 2022. Ukraine, 1 publications between 2022 and 2022, average publication date October 2022.

To see the data from this visualization as text, click here.
Osokina's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (12)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.